Ovarian suppression does not prevent damage from chemotherapy

NEW YORK (Reuters Health) - Cotreatment with gonadotropin-releasing hormone (GnRH) analogues does not protect against ovarian damage in patients treated with cyclophosphamide-based chemotherapy, according to a new study.
Source: Modern Medicine - Category: Journals (General) Source Type: news